evaluation of mrna expression levels of cyp51a and mdr1, candidate genes for voriconazole resistance in aspergillus flavus

conclusions our experimental and in silico findings may provide new insight in the complex molecular pathways of drug resistance and also could assist design an efficient therapeutic strategy for aspergillosis treatment. results four out of five isolates revealed cyp51a and mdr1 mrna overexpression. interestingly, the isolate, which was negative for cyp51a and mdr1 mrna expression showed a high voriconazole minimum inhibitory concentration (mic). furthermore, a computational-based analysis predicted that voriconazole resistance could be mediated through cooperation with a network protein interaction. background voriconazole resistance (vrc-r) in aspergillus flavus isolates impacts the management of aspergillosis, since azoles are the first choice for prophylaxis and therapy. however, to the best of our knowledge, the mechanisms underlying voriconazole resistance are poorly understood. objectives the present study was designed to evaluate mrna expression levels of cyp51a and mdr1 genes in voriconazole resistant a. flavus by a real-time reverse transcriptase polymerase chain reaction (rt-pcr) technique. materials and methods five a. flavus isolates with resistance to vrc were examined by a rt-pcr approach.